As Duane Boise, CEO of MMJ International Holdings, recently remarked:"Patients deserve treatments backed by science, not guesswork. If cannabinoid therapies are going to become part of modern medicine ...

TV18, the fourth edition draws more than 250 nominations from 90+ global companiesBOSTON--(BUSINESS WIRE)--$LTTS #AI--The ...

YolTech Therapeutics, a late clinical-stage biotechnology company developing in vivo gene-editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved the ...

WILMINGTON, DE / ACCESS Newswire / March 13, 2026 / Electric Metals (USA) Limited (TSXV:EML)(OTCQB:EMUSF) (the "Company") a U.S.-based critical minerals and advanced materials company, today announced ...

AUSTIN, TX / ACCESS Newswire / March 13, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...

Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

New 2026 analysis finds Spain's national digital backbone is no longer the differentiator; autonomous communities and provider groups now compete on interoperability, cyber resilience, and hospital ...

TAMPA, FL / ACCESS Newswire / March 13, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization ...

Expanded Charitable Funding will Support Phase 1 Multiple Ascending Dose Trial and Long-Term Toxicology Studies for TIX100, a Novel Oral Therapy Targeting Beta Cell Health in Type 1 DiabetesBIRMINGHAM ...

Global Neonatal Intensive Care Respiratory Devices Market OverviewThe global neonatal intensive care respiratory devices market is projected to grow at a compound annual growth rate of approximately 6 ...

Encouraging preclinical and translational data supporting DNase-based approaches to target NETs in difficult-to-treat cancersStrategic focus on investigator-initiated exploratory studies and ...